PhRMA
APRIL 24, 2023
If we needed any more proof that the health insurance and pharmacy benefit manager (PBM) industries are one and the same, look no further than a new ad campaign by America’s Health Insurance Plans (AHIP). With PBMs facing increasing scrutiny on Capitol Hill, AHIP is hitting the airwaves to deflect any responsibility for the high cost of medicine many people face.
Drug Topics
APRIL 24, 2023
The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
APRIL 24, 2023
Nonprofit hospitals are supposed to help provide access to crucial treatment and services in our most vulnerable communities. But recent research adds to the mountain of evidence showing nonprofit hospitals continue to fall short in their community benefit. For example, many nonprofit hospitals participate in the federal 340B Drug Pricing Program, where eligible large nonprofit hospitals can buy deeply discounted 340B medicines and then turn around and charge both uninsured patients and insuranc
Drug Topics
APRIL 24, 2023
Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 24, 2023
A new book on the U.S. response to the Covid-19 pandemic paints a picture of a country ill-prepared to cope with a dangerous biological foe, riven by partisan politics, and led by people who saw little political gain in taking ownership of managing the crisis. It also describes a country that remains ill-equipped to battle the next pandemic or major disease threat, though it lays out changes that could strengthen the country’s position.
Drug Topics
APRIL 24, 2023
The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
APRIL 24, 2023
Home care industry touts bipartisan bill to expand Medicare in-home benefits, reimbursement dmuoio Mon, 04/24/2023 - 14:08
Pharmacy Times
APRIL 24, 2023
The crucial role of self-care pharmacy practice requires that pharmacists develop a robust understanding of the implications of the current and proposed regulatory changes for nonprescription drugs.
Fierce Healthcare
APRIL 24, 2023
As generative AI makes headway in healthcare, executive leaders still struggle to scale up breakthrough tech aburky Mon, 04/24/2023 - 13:23
Pharmacy Times
APRIL 24, 2023
A 10% increase in the proportion of adults aged 50 years or older was associated with a 1.2% increase in pneumococcal vaccination coverage.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
APRIL 24, 2023
Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. While 80% of the world’s population practices some form of traditional medicine, according to the World Health Organization (WHO), the practice is regularly discredited due to a lack of scientific support and regulation as well as evidence of negative side effects with cert
Pharmacy Times
APRIL 24, 2023
Infusion reactions in the switching group did not occur with switching, but rather only with reference trastuzumab administration.
STAT
APRIL 24, 2023
Marburg could soon become the second virus in the past year to have experimental vaccine candidates ready for testing under an emergency use listing. Until this point, no licensed vaccines or treatments are available for Marburg. That was also the case with the Sudan strain of Ebola, which caused an outbreak in Uganda with 164 cases and more than 55 deaths in the last quarter of 2022.
Drug Topics
APRIL 24, 2023
Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
APRIL 24, 2023
Included in this issue of European Pharmaceutical Review : FOREWORD New quality requirements for tobacco products David Elder, David P Elder Consultancy QA/QC MASS SPECTROMETRY The benefits of mass spectrometry for expediting biologics to patients Ian Anderson, Mostafa Zarei and Qifeng Zhang, Lonza IN-DEPTH FOCUS: Bioprocessing/Bioproduction Realising the potential of AAV gene therapies Rajiv Vaidya, Andelyn Biosciences What gene therapy manufacturers can gain from collaboration Neil Almstead,
Hospital Pharmacy Europe
APRIL 24, 2023
Using pembrolizumab plus gemcitabine and cisplatin improves overall survival compared to chemotherapy alone in advanced biliary tract cancer Patients with biliary tract cancers invariably present at a late stage when curative surgery is not possible. The current treatment for advanced biliary cancer involves chemotherapy with cisplatin plus gemcitabine and which improves survival.
Pharmaceutical Technology
APRIL 24, 2023
The National Institute for Health and Care Excellence (NICE) has published a final draft guidance recommending the use of Darzalex (daratumumab) with bortezomib and dexamethasone (DVd) for adults with previously treated multiple myeloma. The draft guidance is open for feedback from consultees after which the document and its recommendations will be used to establish the organization’s guidance on the use of this combination regimen for patients in the UK’s National Health Services.
European Pharmaceutical Review
APRIL 24, 2023
Realising the potential of AAV gene therapies Dr Rajiv Vaidya, Head of Manufacturing Science & Technology at Andelyn Biosciences, explores strategies for improving the scalability and cost‑effectiveness of AAV production while maintaining regulatory compliance. What gene therapy manufacturers can gain from collaboration Neil Almstead, Chief Technical Operations Officer at PTC Therapeutics, shares his view on why collaboration is key to streamlining manufacture of gene therapies.
Pharmaceutical Technology
APRIL 24, 2023
The Covid-19 pandemic pushed the healthcare industry toward rapid digitalisation, with the rise of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology now changing the way healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment for psychological and neurological disorders.
Fierce Pharma
APRIL 24, 2023
Apellis hits setback in ALS trial after pair of pegcetacoplan approvals fkansteiner Mon, 04/24/2023 - 10:56
Pharmacy Times
APRIL 24, 2023
The results of a review, published in Cureus, show that the medications reduced the risk of HF.
The Honest Apothecary
APRIL 24, 2023
Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.
Fierce Healthcare
APRIL 24, 2023
AppliedVR's latest partnership expands covered access to VR therapeutics for veterans, active military hlandi Mon, 04/24/2023 - 10:46
European Pharmaceutical Review
APRIL 24, 2023
Included in this Guide to Testing: Exploring low endotoxin recovery in drug products Chiara Celli, Marco Mingolla and Fabrizio Lecce from the Institute of Biomedical Research Antoine Marxer, discuss low endotoxin recovery in drug products analysed using the monocyte activation test. Sustainability in BET from your endotoxin experts Associates of Cape Cod International, Inc. explores the future of sustainable LAL testing.
Drug Store News
APRIL 24, 2023
Placer.ai reports that following a strong January, retail traffic slowed somewhat as consumers continued adjusting their spending habits to inflationary prices.
Pharmacy Times
APRIL 24, 2023
Lowering blood pressure could be dangerous for people with normal blood pressure.
Drug Store News
APRIL 24, 2023
Attendees got the chance to connect with new and existing business partners and enjoy a wide assortment of cuisine.
Pharmacy Times
APRIL 24, 2023
Choosing the best biosimilar based on reimbursement can be challenging.
PharmaVoice
APRIL 24, 2023
Two decades after the Human Genome Project, scientists are on the brink of uncovering its full potential for drug development.
Fierce Pharma
APRIL 24, 2023
After delays, bluebird's sickle cell gene therapy finally lands at the FDA's desk zbecker Mon, 04/24/2023 - 11:15
Fierce Healthcare
APRIL 24, 2023
AHIP ad campaign: Big Pharma continues 'deceive and divert attention' on drug prices pminemyer Mon, 04/24/2023 - 12:12
PharmExec
APRIL 24, 2023
Cost Plus Drug Co. adds J&J's Janssen medications to its offerings, increasing affordability for diabetes patients.
PharmaVoice
APRIL 24, 2023
Dr. Preeti Parikh sees parallels between promoting health equity and current DE&I challenges in the workplace.
Fierce Pharma
APRIL 24, 2023
Johnson & Johnson's PARP combo nabs first global nod but faces tough fight against AZ, Merck's Lynparza aliu Mon, 04/24/2023 - 10:32
Expert insights. Personalized for you.
191 
Let's personalize your content